Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery
JO Eloy, MC de Souza, R Petrilli, JPA Barcellos… - Colloids and surfaces B …, 2014 - Elsevier
Although hydrophilic small molecule drugs are widely used in the clinic, their rapid
clearance, suboptimal biodistribution, low intracellular absorption and toxicity can limit their …
clearance, suboptimal biodistribution, low intracellular absorption and toxicity can limit their …
[HTML][HTML] Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production
A El-Sayed, M Kamel - Environmental Science and Pollution Research, 2020 - Springer
In the last decades, nanotechnology-based tools started to draw the attention of research
worldwide. They offer economic, rapid, effective, and highly specific solutions for most …
worldwide. They offer economic, rapid, effective, and highly specific solutions for most …
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer
Semiconductor quantum dots and nanoparticles composed of metals, lipids or polymers
have emerged with promising applications for early detection and therapy of cancer …
have emerged with promising applications for early detection and therapy of cancer …
PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery
S Cerritelli, D Velluto, JA Hubbell - Biomacromolecules, 2007 - ACS Publications
Under appropriate conditions, block copolymeric macroamphiphiles will self-assemble in
water to form vesicles, referred to as polymersomes. We report here polymersomes that can …
water to form vesicles, referred to as polymersomes. We report here polymersomes that can …
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
C Guiducci, G Ott, JH Chan, E Damon… - The Journal of …, 2006 - rupress.org
Human plasmacytoid dendritic cells (PDCs) can produce interferon (IFN)-α and/or mature
and participate in the adaptive immune response. Three classes of CpG oligonucleotide …
and participate in the adaptive immune response. Three classes of CpG oligonucleotide …
Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles
Parasitic diseases such as malaria, leishmaniasis, and trypanosomiasis represent a
significant global burden and pose a great challenge to drug discovery and delivery …
significant global burden and pose a great challenge to drug discovery and delivery …
Review on Experimental Treatment Strategies Against Trypanosoma cruzi
AL Mazzeti, P Capelari-Oliveira, MT Bahia… - Journal of …, 2021 - Taylor & Francis
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …
Therapeutical approaches under investigation for treatment of Chagas disease
Introduction: A century after its discovery, American trypanosomiasis or Chagas disease
remains a serious health problem in Latin America, where it affects around 7–8 million …
remains a serious health problem in Latin America, where it affects around 7–8 million …
Small molecule therapeutic-loaded liposomes as therapeutic carriers: from development to clinical applications
While small hydrophilic therapeutic molecules have proved to be exceptionally effective in
curing diseases, their in vivo efficacy remains low. Small molecule therapeutics infused in …
curing diseases, their in vivo efficacy remains low. Small molecule therapeutics infused in …
Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis
MJ Morilla, EL Romero - Nanomedicine, 2015 - Taylor & Francis
Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma
cruzi. After a mostly clinically silent acute phase, the disease becomes a lifelong chronic …
cruzi. After a mostly clinically silent acute phase, the disease becomes a lifelong chronic …